News for hackers. Stuff that matters.
Re:How Neglecting Minorities in Medical Research Has Led to ... by PaulHoule on Thursday January 11, 2018 @06:20PM (#16129019)
Part of it is a lack of financial incentives on the part of the drug companies. Most pharmaceutical research is aimed at marketing drugs.

Take the example of hypertension, which is more prevalent among blacks than whites. At the moment, all of the major antihypertensive families are available as generic drugs. The best way to help black people quickly is to do a comparative study of drugs already on the market. No drug company is going to do that because they won't be able to capture the value if the drugs are generic.

Maybe a drug company could try to develop a drug which is particularly good for blacks, but it will take a decade, may not work, won't sell as well (fewer people), and then it will be an expensive new drug and people will complain about the cost.

Re:How Neglecting Minorities in Medical Research Has Led to ... by blaurenceclark on Thursday January 11, 2018 @06:24PM (#16129045)
That's 100% true, I'm not saying we have to create a new drug, but define what is the best treatments available, as well as take that into account when the treatments are being made. Especially as there become more black people if there is a treatment just for that minority it may be a quite profitable route for them.

Further down in the comments somewhere I posted another comment where it's as simple as certain chemo's cause toxicity levels in Asians where they don't in white Americans. So simply lowering the dosage would fix the problem but because that wasn't involved in the original research it wasn't known for quite sometime and Asian populations suffered.

When I say "focus on minorities for research" working any solution is fine, simple or not.